Sano Genetics

Taking part in research is currently hard to do and a poor experience for the patient. Finding out about opportunities is haphazard, and there is often little meaningful return for those who take the time and care to get involved. The result is that organisations with cutting edge theories and medicines to test, can’t find the right patients to work with. To discover cures for the diseases that affect us and our families, we need to enable people to contribute to medical science, effortlessly and on their own terms. We founded Sano to enable medical research that is data-driven and puts patients at the centre of the experience.

Today, the Sano platform is helping tens of thousands of people connect to relevant research projects including clinical trials which are testing new medicines. By the end of 2022, we expect to be helping hundreds of thousands of people.

Sano is the platform that patient-centric personalized medicine research is built on.

Sano matches those with medical conditions with opportunities to contribute to research, via our unique online platform. We also provide personalised medical insights, information and recommendations. The platform is private-by-design. We feel strongly that people should be in full control of their sensitive health data and choose who can access it.

We help pharma, biotechs, biobanks, and patient organizations to run digital and at-home personalized medicine research that is faster, and more cost-effective than traditional approaches.

Our current focus is on neurological and immune conditions (Parkinson’s Disease, Multiple Sclerosis, Long COVID amongst others).

Today, the Sano platform is helping thousands of people connect to relevant research projects including clinical trials which are testing new medicines.